neostigmine has been researched along with Neurogenic Bowel in 1 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
Neurogenic Bowel: Loss or absence of normal intestinal function due to nerve damage or birth defects. It is characterized by the inability to control the elimination of stool from the body.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Korsten, MA | 1 |
| Lyons, BL | 1 |
| Radulovic, M | 1 |
| Cummings, TM | 1 |
| Sikka, G | 1 |
| Singh, K | 1 |
| Hobson, JC | 1 |
| Sabiev, A | 1 |
| Spungen, AM | 1 |
| Bauman, WA | 1 |
1 trial available for neostigmine and Neurogenic Bowel
| Article | Year |
|---|---|
Delivery of neostigmine and glycopyrrolate by iontophoresis: a nonrandomized study in individuals with spinal cord injury.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Cholinesterase Inhibitors; Dose-Response Relat | 2018 |